Sign in

CIK 0001447028

  • Non-accelerated filer
  • Smaller reporting company

Arbutus Biopharma Corp

Sign in to watch
Ticker
ABUS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980597776
Phone
+1 604-419-3200
Business address
701 VETERANS CIRCLE, WARMINSTER, PA, 18974
Former names
TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-01 Howard Elizabeth EVP, GC, Compliance Grant or award +69,700 86,024
2023-02-01 Howard Elizabeth EVP, GC, Compliance Grant or award · Stock Option (Right to Buy) +278,700 278,700
2022-01-20 Howard Elizabeth Chief Compliance Officer Grant or award · Stock Option (Right to Buy) +237,500 $2.81 $667K 237,500
2021-02-13 Howard Elizabeth Chief Compliance Officer Grant or award · Stock Options +200,000 200,000
2020-02-17 Howard Elizabeth Chief Compliance Officer Grant or award · Stock Options +79,500 79,500
2019-03-01 Howard Elizabeth Executive VP & General Counsel Grant or award · Employee Stock Option (Right to Buy) +137,500 137,500
2018-04-16 Howard Elizabeth Exec. VP & General Counsel Grant or award · Employee Stock Option (Right to Buy) +150,000 150,000
2017-03-24 Howard Elizabeth Exec. VP & General Counsel Grant or award · Employee Stock Option (Right to Buy) +125,000 125,000
2016-03-15 Howard Elizabeth Exec. VP & General Counsel Grant or award · Employee Stock Option (Right to Buy) +120,000 120,000

Page 1 of 1 · 9 trades